CN Stock MarketDetailed Quotes

Shanghai C&D INNOSTIC Medical Technology Group (301584)

Watchlist
  • 21.36
  • +0.57+2.74%
Noon Break Jun 12 11:30 CST
9.00BMarket Cap31.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai C&D INNOSTIC Medical Technology Group (301584) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
0.15%4.52B
8.41%19.43B
10.18%14.86B
12.18%9.83B
13.23%4.52B
16.06%17.92B
13.49B
16.84%8.76B
3.99B
29.97%15.44B
Operating revenue
0.15%4.52B
8.41%19.43B
10.18%14.86B
12.18%9.83B
13.23%4.52B
16.06%17.92B
--13.49B
16.84%8.76B
--3.99B
29.97%15.44B
Other operating revenue
----
9.25%44.14M
----
-26.49%15.74M
----
38.36%40.4M
----
74.15%21.4M
----
88.25%29.2M
Total operating cost
-0.14%4.38B
7.92%18.88B
9.44%14.39B
11.35%9.52B
12.30%4.38B
15.99%17.49B
13.15B
16.78%8.55B
3.9B
30.23%15.08B
Operating cost
0.15%4.16B
7.92%17.89B
9.54%13.67B
11.73%9.05B
--4.15B
16.46%16.57B
--12.48B
17.06%8.1B
----
29.76%14.23B
Operating tax surcharges
29.36%8.76M
22.78%34.03M
42.12%22.95M
7.72%15.32M
--6.77M
23.13%27.71M
--16.15M
28.48%14.22M
----
40.98%22.51M
Operating expense
-4.50%128.15M
12.90%583.12M
9.04%419.07M
7.71%277.41M
--134.19M
3.78%516.51M
--384.33M
7.52%257.56M
----
30.86%497.68M
Administration expense
8.03%50.97M
12.21%218.15M
17.15%159.2M
8.11%97.94M
--47.18M
10.53%194.42M
--135.9M
10.92%90.59M
----
32.49%175.91M
Financial expense
-37.12%22.72M
-16.31%131.92M
-13.43%100.52M
-10.78%70.12M
--36.13M
25.68%157.63M
--116.11M
43.12%78.59M
----
70.81%125.42M
-Interest expense (Financial expense)
-35.99%22.36M
-18.36%132.27M
-12.96%104.26M
-13.17%70.61M
--34.92M
21.92%162.01M
--119.79M
38.26%81.32M
----
70.39%132.88M
-Interest Income (Financial expense)
44.15%-1.22M
12.44%-7.37M
10.04%-5.96M
30.60%-3.33M
---2.19M
-8.09%-8.42M
---6.63M
-23.59%-4.8M
----
-20.96%-7.79M
Research and development
25.84%6.32M
7.88%28.49M
4.91%18.08M
5.65%11.75M
--5.02M
-17.12%26.41M
--17.24M
-30.53%11.12M
----
133.94%31.87M
Credit Impairment Loss
27.37%-16.67M
-209.59%-44.92M
-38.72%-34.65M
-73.91%-33.8M
---22.95M
-31.05%-14.51M
---24.98M
-50.34%-19.43M
----
67.92%-11.07M
Asset Impairment Loss
50.67%-14.39M
-96.11%-58.65M
-29.75%-41.01M
-101.51%-30.01M
---29.16M
12.66%-29.91M
---31.61M
35.41%-14.89M
----
-72.16%-34.24M
Other net revenue
39.73%-30.87M
-100.72%-96.55M
-19.83%-75.88M
-67.17%-66.89M
-51.21M
-3.13%-48.1M
-63.32M
-18.01%-40.01M
0
9.86%-46.64M
Invest income
-584.98%-2.49M
34.83%-8.1M
35.87%-5.72M
26.18%-4.98M
---363.67K
-91.44%-12.44M
---8.93M
-371.57%-6.74M
----
-113.44%-6.5M
Asset deal income
-85.77%46.29K
138.76%2.12M
-48.97%319.91K
-50.60%306.51K
--325.28K
292.97%888.5K
--626.88K
839.00%620.47K
----
-31.54%226.1K
Other revenue
180.37%2.63M
65.42%13.01M
231.50%5.19M
265.16%1.59M
--939.19K
59.10%7.86M
--1.56M
-87.37%434.54K
----
-8.07%4.94M
Operating profit
40.78%115.72M
19.10%452.25M
44.12%390.65M
41.25%239.51M
43.92%82.2M
21.20%379.71M
271.06M
19.40%169.57M
57.11M
26.06%313.28M
Add:Non operating Income
193.45%151.17K
28.04%1.35M
-34.54%702.65K
-61.01%293.25K
--51.51K
-62.09%1.06M
--1.07M
-51.98%752.08K
----
131.10%2.79M
Less:Non operating expense
-65.09%212.13K
-28.06%2.08M
-39.70%1.63M
80.77%1.48M
--607.67K
227.16%2.89M
--2.7M
30.98%818.66K
----
99.80%884.01K
Total profit
41.66%115.66M
19.49%451.52M
44.65%389.73M
40.60%238.32M
44.24%81.64M
19.89%377.87M
269.43M
18.56%169.5M
56.6M
26.43%315.18M
Less:Income tax cost
46.87%31.13M
11.81%116.37M
48.32%105.68M
35.31%65.53M
--21.19M
17.87%104.08M
--71.25M
21.84%48.43M
----
47.01%88.31M
Net profit
39.83%84.53M
22.41%335.15M
43.33%284.05M
42.72%172.8M
59.44%60.45M
20.68%273.79M
198.18M
17.30%121.08M
37.91M
19.90%226.88M
Net profit from continuing operation
39.83%84.53M
22.41%335.15M
43.33%284.05M
42.72%172.8M
--60.45M
20.68%273.79M
--198.18M
17.30%121.08M
----
19.90%226.88M
Less:Minority Profit
72.23%19.35M
44.05%65.51M
36.62%54.22M
44.21%35.76M
--11.23M
48.75%45.48M
--39.68M
82.64%24.8M
----
104.64%30.57M
Net profit of parent company owners
32.44%65.18M
18.10%269.63M
45.01%229.83M
42.34%137.04M
54.87%49.21M
16.31%228.31M
--158.5M
7.40%96.28M
--31.78M
12.64%196.3M
Earning per share
Basic earning per share
7.14%0.15
12.50%0.72
45.45%0.64
40.74%0.38
--0.14
16.36%0.64
--0.44
8.00%0.27
----
12.24%0.55
Diluted earning per share
7.14%0.15
10.94%0.71
45.45%0.64
----
--0.14
--0.64
--0.44
----
----
----
Other composite income
Total composite income
39.83%84.53M
22.41%335.15M
43.33%284.05M
42.72%172.8M
60.45M
20.68%273.79M
198.18M
17.30%121.08M
19.90%226.88M
Total composite income of parent company owners
32.44%65.18M
18.10%269.63M
45.01%229.83M
42.34%137.04M
--49.21M
16.31%228.31M
--158.5M
7.40%96.28M
----
12.64%196.3M
Total composite income of minority owners
72.23%19.35M
44.05%65.51M
36.62%54.22M
44.21%35.76M
--11.23M
48.75%45.48M
--39.68M
82.64%24.8M
----
104.64%30.57M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Rongcheng Certified Public Accountants (Special General Partnership)
--
--
--
Rongcheng Certified Public Accountants (Special General Partnership)
--
--
--
Rongcheng Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 0.15%4.52B8.41%19.43B10.18%14.86B12.18%9.83B13.23%4.52B16.06%17.92B13.49B16.84%8.76B3.99B29.97%15.44B
Operating revenue 0.15%4.52B8.41%19.43B10.18%14.86B12.18%9.83B13.23%4.52B16.06%17.92B--13.49B16.84%8.76B--3.99B29.97%15.44B
Other operating revenue ----9.25%44.14M-----26.49%15.74M----38.36%40.4M----74.15%21.4M----88.25%29.2M
Total operating cost -0.14%4.38B7.92%18.88B9.44%14.39B11.35%9.52B12.30%4.38B15.99%17.49B13.15B16.78%8.55B3.9B30.23%15.08B
Operating cost 0.15%4.16B7.92%17.89B9.54%13.67B11.73%9.05B--4.15B16.46%16.57B--12.48B17.06%8.1B----29.76%14.23B
Operating tax surcharges 29.36%8.76M22.78%34.03M42.12%22.95M7.72%15.32M--6.77M23.13%27.71M--16.15M28.48%14.22M----40.98%22.51M
Operating expense -4.50%128.15M12.90%583.12M9.04%419.07M7.71%277.41M--134.19M3.78%516.51M--384.33M7.52%257.56M----30.86%497.68M
Administration expense 8.03%50.97M12.21%218.15M17.15%159.2M8.11%97.94M--47.18M10.53%194.42M--135.9M10.92%90.59M----32.49%175.91M
Financial expense -37.12%22.72M-16.31%131.92M-13.43%100.52M-10.78%70.12M--36.13M25.68%157.63M--116.11M43.12%78.59M----70.81%125.42M
-Interest expense (Financial expense) -35.99%22.36M-18.36%132.27M-12.96%104.26M-13.17%70.61M--34.92M21.92%162.01M--119.79M38.26%81.32M----70.39%132.88M
-Interest Income (Financial expense) 44.15%-1.22M12.44%-7.37M10.04%-5.96M30.60%-3.33M---2.19M-8.09%-8.42M---6.63M-23.59%-4.8M-----20.96%-7.79M
Research and development 25.84%6.32M7.88%28.49M4.91%18.08M5.65%11.75M--5.02M-17.12%26.41M--17.24M-30.53%11.12M----133.94%31.87M
Credit Impairment Loss 27.37%-16.67M-209.59%-44.92M-38.72%-34.65M-73.91%-33.8M---22.95M-31.05%-14.51M---24.98M-50.34%-19.43M----67.92%-11.07M
Asset Impairment Loss 50.67%-14.39M-96.11%-58.65M-29.75%-41.01M-101.51%-30.01M---29.16M12.66%-29.91M---31.61M35.41%-14.89M-----72.16%-34.24M
Other net revenue 39.73%-30.87M-100.72%-96.55M-19.83%-75.88M-67.17%-66.89M-51.21M-3.13%-48.1M-63.32M-18.01%-40.01M09.86%-46.64M
Invest income -584.98%-2.49M34.83%-8.1M35.87%-5.72M26.18%-4.98M---363.67K-91.44%-12.44M---8.93M-371.57%-6.74M-----113.44%-6.5M
Asset deal income -85.77%46.29K138.76%2.12M-48.97%319.91K-50.60%306.51K--325.28K292.97%888.5K--626.88K839.00%620.47K-----31.54%226.1K
Other revenue 180.37%2.63M65.42%13.01M231.50%5.19M265.16%1.59M--939.19K59.10%7.86M--1.56M-87.37%434.54K-----8.07%4.94M
Operating profit 40.78%115.72M19.10%452.25M44.12%390.65M41.25%239.51M43.92%82.2M21.20%379.71M271.06M19.40%169.57M57.11M26.06%313.28M
Add:Non operating Income 193.45%151.17K28.04%1.35M-34.54%702.65K-61.01%293.25K--51.51K-62.09%1.06M--1.07M-51.98%752.08K----131.10%2.79M
Less:Non operating expense -65.09%212.13K-28.06%2.08M-39.70%1.63M80.77%1.48M--607.67K227.16%2.89M--2.7M30.98%818.66K----99.80%884.01K
Total profit 41.66%115.66M19.49%451.52M44.65%389.73M40.60%238.32M44.24%81.64M19.89%377.87M269.43M18.56%169.5M56.6M26.43%315.18M
Less:Income tax cost 46.87%31.13M11.81%116.37M48.32%105.68M35.31%65.53M--21.19M17.87%104.08M--71.25M21.84%48.43M----47.01%88.31M
Net profit 39.83%84.53M22.41%335.15M43.33%284.05M42.72%172.8M59.44%60.45M20.68%273.79M198.18M17.30%121.08M37.91M19.90%226.88M
Net profit from continuing operation 39.83%84.53M22.41%335.15M43.33%284.05M42.72%172.8M--60.45M20.68%273.79M--198.18M17.30%121.08M----19.90%226.88M
Less:Minority Profit 72.23%19.35M44.05%65.51M36.62%54.22M44.21%35.76M--11.23M48.75%45.48M--39.68M82.64%24.8M----104.64%30.57M
Net profit of parent company owners 32.44%65.18M18.10%269.63M45.01%229.83M42.34%137.04M54.87%49.21M16.31%228.31M--158.5M7.40%96.28M--31.78M12.64%196.3M
Earning per share
Basic earning per share 7.14%0.1512.50%0.7245.45%0.6440.74%0.38--0.1416.36%0.64--0.448.00%0.27----12.24%0.55
Diluted earning per share 7.14%0.1510.94%0.7145.45%0.64------0.14--0.64--0.44------------
Other composite income
Total composite income 39.83%84.53M22.41%335.15M43.33%284.05M42.72%172.8M60.45M20.68%273.79M198.18M17.30%121.08M19.90%226.88M
Total composite income of parent company owners 32.44%65.18M18.10%269.63M45.01%229.83M42.34%137.04M--49.21M16.31%228.31M--158.5M7.40%96.28M----12.64%196.3M
Total composite income of minority owners 72.23%19.35M44.05%65.51M36.62%54.22M44.21%35.76M--11.23M48.75%45.48M--39.68M82.64%24.8M----104.64%30.57M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Rongcheng Certified Public Accountants (Special General Partnership)------Rongcheng Certified Public Accountants (Special General Partnership)------Rongcheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 0.00%
Sample Name
Sample Code
 -3.68%
Sample Name
Sample Code
 -4.75%
4
KUNLUN ENERGY
00135
-5.91%
5
CHINA OILFIELD
02883
-6.10%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +13.44%
Sample Name
Sample Code
 +2.45%
Sample Name
Sample Code
 +2.44%
4
Emdoor Information
001314
-4.78%
5
Thunder Software Technology
300496
-5.83%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran conflict shows signs of easing. On the 11th, Eastern Time, Trump revealed that the United States and Iran are expected to reac Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -